Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review.


Journal

Oncology
ISSN: 1423-0232
Titre abrégé: Oncology
Pays: Switzerland
ID NLM: 0135054

Informations de publication

Date de publication:
2023
Historique:
received: 15 09 2022
accepted: 01 12 2022
medline: 5 4 2023
pubmed: 6 1 2023
entrez: 5 1 2023
Statut: ppublish

Résumé

Diffuse gliomas are the most frequent neoplasms in adolescent and young adults (AYAs), especially high-grade gliomas, which have the highest mortality rate. Recent histo-molecular advances are in favour of specialized therapeutic management of AYA patients, which we have analysed in this comprehensive review of the literature. A literature search was conducted to identify all studies concerning diffuse gliomas and AYAs (15-39 years). We assessed epidemiology, clinical and imaging findings, histo-molecular characteristics, neurosurgical and neuro-oncological management, prognosis, and health-related quality of life. Diffuse gliomas remain the most frequent brain tumours in the AYA population. Symptoms mainly depend on the tumour location, which varies due to histo-molecular profiles. Specific imaging patterns of histo-molecular subtypes of diffuse gliomas are identified; however, no specific pattern related to the age group has been identified. The literature review favours optimizing the extent of surgical resection for diffuse gliomas, whichever the grade, and suggests a dedicated management for these patients. It seems more relevant to consider the treatment according to the histo-molecular profile of the diffuse glioma rather than the age group. Clinical trials will allow AYA patients to benefit from innovative therapies that could improve their outcome. This literature review suggests the need for a close and long-term psychological follow-up for AYA patients with brain tumour during the transitional care, during adulthood, as well as for their family members. Collaborative efforts are needed between paediatric and adult neurosurgical and neuro-oncological teams, to move forward in the therapeutic management of AYA patients harbouring diffuse gliomas.

Sections du résumé

BACKGROUND BACKGROUND
Diffuse gliomas are the most frequent neoplasms in adolescent and young adults (AYAs), especially high-grade gliomas, which have the highest mortality rate. Recent histo-molecular advances are in favour of specialized therapeutic management of AYA patients, which we have analysed in this comprehensive review of the literature.
SUMMARY CONCLUSIONS
A literature search was conducted to identify all studies concerning diffuse gliomas and AYAs (15-39 years). We assessed epidemiology, clinical and imaging findings, histo-molecular characteristics, neurosurgical and neuro-oncological management, prognosis, and health-related quality of life.
KEY MESSAGES CONCLUSIONS
Diffuse gliomas remain the most frequent brain tumours in the AYA population. Symptoms mainly depend on the tumour location, which varies due to histo-molecular profiles. Specific imaging patterns of histo-molecular subtypes of diffuse gliomas are identified; however, no specific pattern related to the age group has been identified. The literature review favours optimizing the extent of surgical resection for diffuse gliomas, whichever the grade, and suggests a dedicated management for these patients. It seems more relevant to consider the treatment according to the histo-molecular profile of the diffuse glioma rather than the age group. Clinical trials will allow AYA patients to benefit from innovative therapies that could improve their outcome. This literature review suggests the need for a close and long-term psychological follow-up for AYA patients with brain tumour during the transitional care, during adulthood, as well as for their family members. Collaborative efforts are needed between paediatric and adult neurosurgical and neuro-oncological teams, to move forward in the therapeutic management of AYA patients harbouring diffuse gliomas.

Identifiants

pubmed: 36603564
pii: 000528588
doi: 10.1159/000528588
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-251

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Alexandre Roux (A)

Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.
IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.

Marc Zanello (M)

Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.
IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.

Giorgia Antonia Simboli (G)

Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.
IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.

Pascale Varlet (P)

IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.
Service de Neuropathologie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.

Arnault Tauziede-Espariat (A)

IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.
Service de Neuropathologie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.

Kévin Beccaria (K)

Service de Neurochirurgie Pédiatrique, Hôpital Necker Enfants-Malades, AP-HP, Paris, France.

Thomas Blauwblomme (T)

Service de Neurochirurgie Pédiatrique, Hôpital Necker Enfants-Malades, AP-HP, Paris, France.

Stéphanie Puget (S)

Service de Neurochirurgie Pédiatrique, Hôpital Necker Enfants-Malades, AP-HP, Paris, France.

Catherine Oppenheim (C)

IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.
Service de Neuroradiologie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.

Volodia Dangouloff-Ros (V)

Service de Neuroradiologie Pédiatrique, Hôpital Necker Enfants-Malades, AP-HP, Paris, France.

Nathalie Boddaert (N)

Service de Neuroradiologie Pédiatrique, Hôpital Necker Enfants-Malades, AP-HP, Paris, France.

Frédéric Dhermain (F)

Service de Radiothérapie, Institut Gustave Roussy, Université Paris Sud, Université Paris Saclay, Villejuif, France.

Christelle Dufour (C)

Service d'Oncologie Pédiatrique, Institut Gustave Roussy, Université Paris Sud, Université Paris Saclay, Villejuif, France.

Jacques Grill (J)

Service d'Oncologie Pédiatrique, Institut Gustave Roussy, Université Paris Sud, Université Paris Saclay, Villejuif, France.

Fabrice Chretien (F)

Service de Neuropathologie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.

Johan Pallud (J)

Service de Neurochirurgie, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte-Anne, Paris, France.
IMABRAIN, INSERM U1266, Institute of Psychiatry and Neuroscience of Paris, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH